TLR agonists are molecules that bind to and activate TLRs. They mimic PAMPs, thus stimulating the immune system. These agonists can be derived from microbial components or synthetically manufactured. Given their ability to enhance immune responses, TLR agonists have become promising components in vaccine formulations.